A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2002
08/14/2002	EP0800399B1 Combined therapeutical treatment of hyperproliferative diseases
08/14/2002	EP0748335B1 Antibiotic stalobacins
08/14/2002	EP0701448B1 Amplification of the vitamin b 12 uptake system using polymers
08/14/2002	EP0672193B1 Use of oligonucleotides having a conserved g 4 core sequence for the preparation of a medicament
08/14/2002	EP0665853B1 Multimeric polyvalent antithrombotic agents
08/14/2002	EP0531425B1 Combination of IGF-I and TGF-beta for bone regeneration
08/14/2002	DE10105041A1 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
08/14/2002	DE10105040A1 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
08/14/2002	DE10105038A1 Tripeptide und Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
08/14/2002	DE10104551A1 Verwendung eines Claudin-4-Liganden in der Therapie und Diagnose von Tumoren Use of a claudin-4 ligands in the therapy and diagnosis of tumors
08/14/2002	DE10102722A1 Verfahren und Testsystem zum Auffinden von Nervenzell-schützenden Substanzen Method and test system for the detection of nerve cell-protective substances
08/14/2002	DE10102392A1 Kombinierte Verwendung von Enzyminhibitoren und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention allergischer Reaktionen vom Typ I nach Gell und Coombs Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prevention of allergic-type reactions after Gell and Coombs I
08/14/2002	DE10100015A1 Sprühbare enzymhaltige Zusammensetzung Sprayable enzyme-containing composition
08/14/2002	CN1364172A Transcriptional activation inhibitory protein
08/14/2002	CN1364093A Improvement of T cell mediated immunity
08/14/2002	CN1364092A Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
08/14/2002	CN1364089A Chronic myeloid leukemia (CML) therapy
08/14/2002	CN1364088A IL6RIL6 chinese for treatment of neurodegenerative diseases
08/14/2002	CN1364087A Methods of treatment and drug screening methods
08/14/2002	CN1364086A Use of interleukin-18 inhibitors to inhibitor tumor metastasis
08/14/2002	CN1364076A Oral form of administration containing probiotic micro-organisms
08/14/2002	CN1364073A Skin care composition for mediating cell to cell communication
08/14/2002	CN1363838A Process for testing bioactivity of insulinotropic hormone secretion peptide
08/14/2002	CN1363681A Activated lymphocyte from umbilical cord blood, preparations containing it as main content and method therefor
08/14/2002	CN1363680A Polypeptide-beta lactamase 20.24 and polynucleotide for coding it
08/14/2002	CN1363679A Polypeptide-serine proteinase 12.32 and polynucleotide for coding it
08/14/2002	CN1363678A Polypeptide-signal peptidase 9.79 and polynucleotide for coding it
08/14/2002	CN1363677A Polypeptide-uracil pyrophosphatase 9.02 and polynucleotide for coding it
08/14/2002	CN1363676A Polypeptide-human RNA unwindase 48.4 and polynucleotide for coding it
08/14/2002	CN1363675A Polypeptide-human ubiquitin C termination hydrolase 24.53 and polynucleotide for coding it
08/14/2002	CN1363674A Polypeptide-protein kinase 17.71 and polynucleotide for coding it
08/14/2002	CN1363673A Polypeptide-human chondriosome aspartate aminotransferase 9.46 and polynucleotide for coding it
08/14/2002	CN1363672A Polypeptide-phosphoenolpyruvate-dependent glycosylphosphate transferase 13.75 and polynucleotide for coding it
08/14/2002	CN1363671A Polypeptide-human sulfotransferase 17.05 and polynucleotide for coding it
08/14/2002	CN1363670A Polypeptid-ephosphoneolpyruvate-dependent glycosylphosphate transferase 13.75 and polynucleotide for coding it
08/14/2002	CN1363669A Polypetpide-ribosyltransferase 32.23 and polynucleotide for coding it
08/14/2002	CN1363668A Polypeptide-phosphoenolpyruvate-dependent glycosylphosphate transferase 9.02 and polynucleotide for coding it
08/14/2002	CN1363667A Polypeptide-peroxidase protein 8.8 and polynucleotide for coding it
08/14/2002	CN1363666A Polypeptide-Cu/Zn superoxide dismutase 11.22 and polynucleotide for coding it
08/14/2002	CN1363665A Polypeptide-superoxide dismutase 9.35 and polynucleotide for coding it
08/14/2002	CN1363664A Polypeptide-short-chain dehydrogenase 9.35 and polynucleotide for coding it
08/14/2002	CN1363663A Polypeptide-NADH dehydrogenase 9.46 and polynucleotide for coding it
08/14/2002	CN1363662A Polypeptide-human tyrosinase 10.01 and polynucleotide for coding it
08/14/2002	CN1363661A Polypeptide-dihydropyrroline-5-carboxylic acid reductase 8.91 and polynucleotide for coding it
08/14/2002	CN1363660A Polypeptide-human glutamyl transfer RNA synthetase 23.76 and polynucleotide for coding it
08/14/2002	CN1363659A Polypeptide-human phosphoribosyl glycinamide synthetase 10.78 and polynucleotide for coding it
08/14/2002	CN1363658A Polypeptide-DNA polymerase 14.78 and polynucleotide for coding it
08/14/2002	CN1363657A Polypeptide-human RNA polymerase I-40KD subunit 10.01 and polynucleotide for coding it
08/14/2002	CN1363656A Polypeptide-ATP systhetase 11.55 and polynucleotide for coding it
08/14/2002	CN1363655A Polypeptide-human RNA polymerase I-40 KD subunit 9.68 and polynuceotide for coding it
08/14/2002	CN1363559A Insulinotropic hormone secretion peptide derivative
08/14/2002	CN1363558A Antibacterial frog skin peptide derivative
08/14/2002	CN1089007C Immunotherapeutic method of treating cancerous diseases by administration of gamma glubulins
08/14/2002	CN1089006C Method of extracting activated hemagglutination factor and inhibitor component (ATI) from tea
08/13/2002	US6434747 Method and system for providing a customized media list
08/13/2002	US6434490 Method of generating chemical compounds having desired properties
08/13/2002	US6433451 Method and electric motor with rotational stator
08/13/2002	US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/13/2002	US6433171 Dipeptide derivatives
08/13/2002	US6433157 Polynucleotides encoding T-cell selective interleukin-4 agonists
08/13/2002	US6433156 Isolated polynucleotide comprising nucleotide sequence encoding polypeptide having at least 95% identity to specified amino acid sequence over entire length
08/13/2002	US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof
08/13/2002	US6433149 Compounds and methods for inhibiting cancer metastasis
08/13/2002	US6433148 Immunoglobulin antibodies with amino acid sequences
08/13/2002	US6433147 Immunoregulators of immune response, hybridoma, human immunoglobulin
08/13/2002	US6433145 Keratinocyte derived interferon
08/13/2002	US6433144 Purification of type i interferons mixtures, human serum albumin and trace proteins, elution
08/13/2002	US6433143 Tie-2 ligands
08/13/2002	US6433142 Megakaryocyte stimulating factors
08/13/2002	US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same
08/13/2002	US6433139 Secreted protein HPEAD48
08/13/2002	US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
08/13/2002	US6433137 TUP1 sequences from Candida albicans and methods for screening agents for inhibiting virulence in Candida albicans using TUP1
08/13/2002	US6433136 Cell density signal protein suitable for treatment of connective tissue injuries and defects
08/13/2002	US6433135 Polyoxyethylene glycol luteinizing hormone releasing hormone bound for serine
08/13/2002	US6432996 Pharmaceutical composition
08/13/2002	US6432968 Immunosuppressants for patients with cancer, autoimmune diseases, and viral infections
08/13/2002	US6432955 Heterocyclic derivatives and their use as antithrombotic agents
08/13/2002	US6432945 Dipeptide derivatives
08/13/2002	US6432944 Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
08/13/2002	US6432933 Malaria therapy; alzheimer's disorders
08/13/2002	US6432927 Compositions and methods for inducing gene expression
08/13/2002	US6432926 Compositions and methods for treating papillomavirus-infected cells
08/13/2002	US6432922 Antitumor agents; angiogenesis inhibitors
08/13/2002	US6432921 Oligopeptides
08/13/2002	US6432920 Peptide library
08/13/2002	US6432919 Bone morphogenetic protein-3 and compositions
08/13/2002	US6432918 Methods and compositions for optimization of oxygen transport by cell-free systems
08/13/2002	US6432917 Anticancer agents
08/13/2002	US6432916 Compounds and methods for treatment and diagnosis of chlamydial infection
08/13/2002	US6432915 Human mitochondrial chaperone protein
08/13/2002	US6432914 Cancer diagnosis; polypeptide
08/13/2002	US6432913 Polypeptide of protein p140 and DNAs encoding it
08/13/2002	US6432708 Human choline acetyltransferase
08/13/2002	US6432707 Isolation of polynucleootide
08/13/2002	US6432706 Method for inhibiting angiogenesis and tumors with the isolated NC1 α6 chain monomer of type IV collagen
08/13/2002	US6432704 Enzymatic rna molecules codes with herpes simplex virus and genes
08/13/2002	US6432703 Isolated polynucleotide sequences
08/13/2002	US6432702 Isolated dna with nucleic acid sequences
08/13/2002	US6432700 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same

1 ... 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 ... 3163